Pharma News

Novel technology combines ACUVUE® daily disposable contact lenses with an established antihistamine in FDA- first in its new category. 

CTI BioPharma announced the U.S FDA has granted accelerated approval to Vonjo (pacritinib) for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera o...

Neurons in the brain coexist with and rely on many other cell types to function properly. 

Sanofi seems to be in a betting mood and has been picking up card after card in licensing deals to bulk up its early-stage pipeline. 

The FDA has granted Breakthrough Therapy designation to Pfizer’s respiratory syncytial vaccine (RSV) candidate, RSVpreF, for the prevention of RSV-associated lower respiratory tract illness in in...

The FDA has told Karyopharm Therapeutics that before the agency will grant market approval for Xpovio (selinexor) for front-line maintenance of advanced or recurrent endometrial cancer, the company...

Fresh data shows that Pfizer's COVID vaccine is far less powerful at preventing infection among children ages 5 to 11 than teens, a finding that could leave some parents of younger children worried...

New Haven, Conn.-based Biohaven Pharmaceutical has struck a global licensing deal with Bristol Myers Squibb (BMS) to develop and market taldefgrobep alfa, an investigational therapy for treating n...

A new methodology simulates counterfactual, time-varying, and dynamic treatment strategies, allowing doctors to choose the best course of action.

AbbVie has filed for an expanded indication for its blockbuster Imbruvica (ibrutinib) as a treatment for chronic graft vs. host disease (cGVHD) in pediatric and adolescent patients who have undergo...

Few would disagree that too much of a good thing is not such a good thing.

The FDA has granted an orphan drug designation (ODD) to the investigational anti-BCMA CAR T-cell therapy CT103A for use as a potential therapeutic option in patients relapsed/refractory multiple my...